Fintel reports that on November 7, 2024, JMP Securities downgraded their outlook for MacroGenics (NasdaqGS:MGNX) from Market ...

In a report released today, Chris Muller from JMP Securities reiterated a Hold rating on Sachem Capital (SACH – Research Report). The ...

JMP Securities analyst Patrick Walravens maintained a Buy rating on Similarweb (SMWB – Research Report) today and set a price target of ...

Arbutus Biopharma (NASDAQ:ABUS – Free Report) had its price target lifted by JMP Securities to $5.00 in a report published on Wednesday,Stock Target Advisor reports. JMP Securities currently has a buy ...

On Monday, JMP Securities initiated coverage on Instil Bio Inc (NASDAQ:TIL) shares with a Market Perform rating. Instil Bio, which went public with an initial public offering as a company ...

Fintel reports that on November 5, 2024, JMP Securities upgraded their outlook for Century Casinos (NasdaqCM:CNTY) from Market Perform to Market Outperform. As of October 22, 2024, the average one ...

Fintel reports that on November 4, 2024, JMP Securities initiated coverage of Instil Bio (NasdaqCM:TIL) with a Market Perform recommendation. As of October 22, 2024, the average one-year price ...

On Monday, JMP Securities made a decisive move by downgrading Sana Biotechnology (NASDAQ:SANA) stock from Market Outperform to Market Perform. This shift in rating comes after Sana Biotechnology ...

Investing.com -- Snap shares rose 2% in premarket trading Wednesday after JMP Securities analysts upgraded the stock from Market Perform to Outperform and set a price target of $17. The firm’s ...

On Tuesday, JMP Securities sustained its Market Outperform rating on Gaming and Leisure Properties (NASDAQ:GLPI), maintaining a $55.00 price target. The firm's analysis highlighted the company's ...